Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says
A Delaware federal judge has cleared radiopharmaceutical companies of allegations they infringed claims in various patents owned by a French unit of Novartis after finding that all of those claims were...To view the full article, register now.
Already a subscriber? Click here to view full article